Tan Lab

Publications

Boutin, C-A; Callegari, M; Florescu, D; Nguyen, M-H; Kaul, D; Avery, R; Chong, P; Fisher, C; Limaye, AP; Clough, L; Daud, A; Lorenzo-Redondo, R; Tan, M; Ison, MG. A phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovirus in hematopoietic stem cell and solid organ transplant recipients. American Journal of Transplantation. 2026.

Xia, M; Ichou, M; Landivar, M; Zhou, P; Vadlamudi, SN; Leruth, A; Nyblade, C; Cox, P; Yuan, L; Goepp, J; Tan, M. Avian Immunoglobulin Y Antibodies Targeting the Protruding or Shell Domain of Norovirus Capsid Protein Neutralize Norovirus Replication in the Human Intestinal Enteroid System. Vaccines. 2025; 13(12).

Xia, M; Huang, P; Vago, FS; Jiang, W; Tan, M. Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus challenges. Vaccine. 2025; 46:126585.

Xia, M; Huang, P; Vago, FS; Jiang, W; Jiang, X; Tan, M. A Nanoparticle Comprising the Receptor-Binding Domains of Norovirus and Plasmodium as a Combination Vaccine Candidate. Vaccines. 2025; 13(1).

Ma, J; Chen, Q; Yuan, F; Cao, M; Gao, J; Yang, C; Tan, M; Xian, R; Gao, L; Kuai, W. Prevalence and genotype distribution of norovirus in Ningxia Hui Autonomous Region, China, from 2011 to 2022. Virology Journal. 2024; 21(1):232.

Huang, P; Xia, M; Vago, FS; Jiang, W; Tan, M. A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge. Vaccines. 2024; 12(8).

Xia, M; Huang, P; Vago, F; Kawagishi, T; Ding, S; Greenberg, HB; Jiang, W; Tan, M. A Viral Protein 4-Based Trivalent Nanoparticle Vaccine Elicited High and Broad Immune Responses and Protective Immunity against the Predominant Rotaviruses. ACS Nano. 2024; 18(8):6673-6689.

Tan, M. The Impact of Norovirus on Children and Adolescents: Implications for Ongoing Vaccine Development. Current Pediatrics Reports. 2024; 13(1):21.

Xia, M; Huang, P; Vago, F; Jiang, W; Tan, M. Pseudovirus Nanoparticles Displaying Plasmodium Circumsporozoite Proteins Elicited High Titers of Sporozoite-Binding Antibody. Vaccines. 2023; 11(11).

Xia, M; López, K; Vago, FS; Huang, P; Auguste, DI; Jiang, W; Auguste, AJ; Tan, M. A bioengineered pseudovirus nanoparticle displaying SARS-CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS-CoV 2 challenge. Biotechnology Journal. 2023; 18(10):e2300130.

Hensley, C; Nyblade, C; Zhou, P; Parreño, V; Ramesh, A; Frazier, A; Frazier, M; Garrison, S; Fantasia-Davis, A; Cai, R; Huang, P-W; Xia, M; Tan, M; Yuan, L. Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix® and a Nanoparticle-Based Trivalent Rotavirus Vaccine Evaluated in Gnotobiotic Pig Models of G4P[6] and G1P[8] Human Rotavirus Infection. Vaccines. 2023; 11(5).

Kawagishi, T; Sánchez-Tacuba, L; Feng, N; Costantini, VP; Tan, M; Jiang, X; Green, KY; Vinjé, J; Ding, S; Greenberg, HB. Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses. Proceedings of the National Academy of Sciences of the United States of America. 2023; 120(9):e2214421120.

Xia, M; Vago, F; Han, L; Huang, P; Nguyen, L; Boons, G-J; Klassen, JS; Jiang, W; Tan, M. The αTSR Domain of Plasmodium Circumsporozoite Protein Bound Heparan Sulfates and Elicited High Titers of Sporozoite Binding Antibody After Displayed by Nanoparticles. International Journal of Nanomedicine. 2023; 18:3087-3107.

Nyblade, C; Hensley, C; Parreño, V; Zhou, P; Frazier, M; Frazier, A; Ramesh, A; Lei, S; Degiuseppe, JI; Tan, M; Yuan, L. A New Gnotobiotic Pig Model of P[6] Human Rotavirus Infection and Disease for Preclinical Evaluation of Rotavirus Vaccines. Viruses. 2022; 14(12).

Rakau, K; Gededzha, M; Peenze, I; Huang, P; Tan, M; Steele, AD; Seheri, LM. The Association between Symptomatic Rotavirus Infection and Histo-Blood Group Antigens in Young Children with Diarrhea in Pretoria, South Africa. Viruses. 2022; 14(12).

Rosario, C; Tan, M. Chlamydia trachomatis RsbU Phosphatase Activity Is Inhibited by the Enolase Product, Phosphoenolpyruvate. Journal of Bacteriology. 2022; 204(10):e0017822.

Wang, K; Sheehan, L; Ramirez, C; Densi, A; Rizvi, S; Ekka, R; Sütterlin, C; Tan, M. A Reverse Genetic Approach for Studying sRNAs in Chlamydia trachomatis. mBio. 2022; 13(4):e0086422.

Muñoz, KJ; Tan, M; Sütterlin, C. Differential Effects of Small Molecule Inhibitors on the Intracellular Chlamydia Infection. mBio. 2022; 13(4):e0107622.

Han, Q; Xue, Z; Tan, M; Wang, L; Chen, H; Zhang, R. Bovine natural antibody IgM inhibits the binding of human norovirus protruding domain to its HBGA receptors. FEBS Open Bio. 2022; 12(8):1489-1497.

Xia, M; Huang, P; Tan, M. A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response. Pharmaceutics. 2022; 14(8).

Wang, C; Kang, H; Tan, M; Cong, J; Su, D; Li, X; Chen, Y. Structural Insight into Terminal Galactose Recognition by Two Non-HBGA Binding GI.3 Noroviruses. Journal of Virology. 2022; 96(13):e0042022.

Ison, MG; Tan, M; Daud, A; Huang, P; Jiang, JX. Quantitative norovirus viral load is not affected by home storage of stool. Transplant Infectious Disease. 2022; 24(3):e13826.

Xia, M; Hoq, MR; Huang, P; Jiang, W; Jiang, X; Tan, M. Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity. Nano Research. 2022; 15(5):4181-4190.